Invention Grant
- Patent Title: Use of anti-FAM19A5 antibodies for treating fibrosis
-
Application No.: US17475214Application Date: 2021-09-14
-
Publication No.: US12077579B2Publication Date: 2024-09-03
- Inventor: Bongcheol Kim , Jae-Keun Lee , Dong Sik Kim
- Applicant: Neuracle Science Co., Ltd.
- Applicant Address: KR Seoul
- Assignee: Neuracle Science Co., Ltd.
- Current Assignee: Neuracle Science Co., Ltd.
- Current Assignee Address: KR Seoul
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- The original application number of the division: US16626621
- Main IPC: G01N33/53
- IPC: G01N33/53 ; C07K16/24 ; G01N33/68 ; A61K39/00
Abstract:
The present disclosure relates to the pharmaceutical use of antagonists (e.g., an antibody or antigen-binding portion thereof) that specifically bind to FAM19A5 to treat or to diagnose a fibrosis and/or a fibrosis-associated disease in a subject in need thereof.
Public/Granted literature
- US20220073601A1 USE OF ANTI-FAM19A5 ANTIBODIES FOR TREATING FIBROSIS Public/Granted day:2022-03-10
Information query
IPC分类:
